由于Lea和Leb抗体而引起的血液溶解输血反应
Hai-Yan Li1, Li-Jun Li2, Deng-Shan Yang2
1Department of Blood Transfusion, Wuming Hospital of Guangxi Medical University, Nanning, China lhy512moon@aliyun.com.
Annals of clinical and laboratory science
|November 13, 2024
概括
一名孕妇因罕见的易斯抗体 (抗-Le a>和抗-Le b>) 而经历了严重的输血反应. 这突显了对抗原阴性血液选择的需要,而不是对易斯抗体的标准交叉匹配.
科学领域:
- 输血医学 输血医学
- 免疫学 免疫学 免疫学
- 产科 产科 产科 产科 产科
背景情况:
- Thalassemia 和 怀孕 呈现 独特 的 输血 挑战 .
- 尽管有标准的交叉匹配,但急性溶血输血反应 (AHTR) 可能会发生.
- 易斯抗体通常被认为是临床上无关紧要的,可引起严重反应.
研究的目的:
- 为了调查在患有沙拉西米亚的孕妇患者中AHTR的原因.
- 突出路易斯抗体在输血反应中的临床意义.
- 在复杂的病例中强调最佳的血液选择策略.
主要方法:
- 患者病史审查和临床观察.
- 使用血型参考实验室 (BTRL) 进行血型和抗体鉴定.
- 对抗体特征 (IgM,IgG) 和输血结果的分析.
主要成果:
- 该患者在输血洗净的红细胞 (RBC) 后发展出AHTR.
- 调查显示存在抗Le a (IgM) 和抗Le b (IgM/IgG) 抗体.
- 这些抗体被确定为严重输血反应的原因.
结论:
- 易斯抗体的罕见组合可以导致临床显著的AHTRs.
- 对患有路易斯抗体的患者来说,抗原阴性血液选择至关重要.
- 当使用聚烯时,可能需要使用替代交叉匹配方法,这是由于易斯抗体的限制.
更多相关视频
11:31Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
Published on: January 2, 2013
18.0K
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
14.3K
相关概念视频
Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
Blood Transfusion
502
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
502
Blood Typing
1.1K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
1.1K
Rh Blood Group
1.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K
Bone Marrow Sampling and Transplants
286
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
286
Cross-reactivity
31.0K
Overview
31.0K
